Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001509181 | SCV001715753 | uncertain significance | not provided | 2020-08-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488314 | SCV002791826 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001509181 | SCV003819080 | uncertain significance | not provided | 2019-10-14 | criteria provided, single submitter | clinical testing |